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ORIGINAL ARTICLE
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ABSTRACT
Epstein-Barr virus (EBV) is also called human herpes virus 4 (HHV-4), has detected 95% of the population and
shows an asymptomatic state. EBV is etiological agent of oral hairy leukoplakia (OHL) in HIV patients. Latent
membrane protein 1 (LMP1), an integral EBV protein can modulate growth, differentiation, induce the expression
of several cells, activation of antigens, and adhesion molecules. The LMP1 gene has been associated with OHL.
Objectives: to determine the prevalence of EBV in saliva and the LMP1 gene in HIV/AIDS patients with EBV
positive. Methods: A cross-sectional was conducted on HIV/AIDS patients. The presence of EBV in saliva was
done by mciroarray PCR. LMP1 is examined by using nested PCR. Results: The research subjects involved 30
HIV/AIDS patients consisting 70% men and 30% women, with 50 % age group of 31-40 years old and 40% had
CD4 counts <200 cells/mm3 (40%). EBV in saliva was found in 26 out of 30 (87%) HIV patients and LMP1 was
detected in 17 patients (65.38%). Conclusion: The high prevalence of EBV in saliva and the LMP1 gene may
increase the risk of OHL. Early screening for EBV infection in patients with HIV/AIDS is important to reduce
the risk of EBV-associated diseases.
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humans. About 95% of the world’s population shows
asymptomatic conditions for life. The virus infects
through saliva or oral cavity contact, but transfusion
transmission has also been reported. EBV can infect
B cells and epithelial cells, and it is generally believed
that epithelial cells in the oropharynx are the primary
location and the location of EBV.7 EBV infection causes
mononucleosis infection, associated with malignancy,
including nasopharyngeal carcinoma (NPC), Burkitt
lymphoma, and Hodgkin’s lymphoma (HL). In
addition, EBV is also an etiological agent of oral hairy
leukoplakia (OHL).6,7,8,9 Contreras, et al. (2014) showed
that EBV has also been detected to cause periodontal
pockets. Escalona, et
 al. (2016) also showed an increase
in periodontal disease in HIV positive patients by EBV
infection. The amount of EBV in saliva and subgingival
plaques has been detected to be higher in HIV positive
patients than in HIV negative patients.10,11,12,13 OHL is a
disorder of EBV-induced mucocutaneous epithelial cell
and is the first pathological manifestation associated

INTRODUCTION
Human immunodeficiency virus (HIV) and acquired
immune deficiency syndrome (AIDS) are challenges
in health care today. Data from the World Health
Organization (WHO) show that around 36 million
people have been infected with HIV.1,2 HIV/AIDS has
developed into one of the major and important health,
and social problems in Indonesia.3 In Indonesia, the
first HIV/AIDS case was found in the province of
Bali in 1987. Until now, HIV/AIDS has spread in 386
districts/cities in all provinces in Indonesia. Every year,
the population of Indonesia infected with HIV/AIDS
is increasing.4,5
HIV-infected patients are at high risk of developing
opportunistic diseases related to Epstein-Barr virus
(EBV).6 EBV, also called human herpes virus 4 (HHV4), is the most common gamma-herpesvirus virus in
81
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research is important so that a strategy can be made to
prevent the emergence of oral lesions related to LMP1
genotypic expression in HIV patients.

with EBV infection, characterized by EBV replication
in epithelial cells.5 The normal oral mucosa consists
of a multilevel squamous epithelium which is divided
into four distinct differentiated layers, namely the basal
layer which is actively mitosis, the spinosum layer
contains keratin, the granular layer and the stratum
corneum containing metabolic inert cells. Basal cells
express keratin K14 and K5, Bcl-2, and EGFR which
maintain proliferation. EGFR is located on the basal
cell surface and when binding to a ligand will affect
mitogenesis and cell migration. When basal cells
differentiate, EGFR is no longer detected, keratin K1
and K10 are expressed suprabasal. The expression
of the anti-apoptotic molecule Bcl-2 in the basal cell
layer decreases during stratification. Differentiation of
epithelial cells involves anoicus, a form of apoptosis
induced by loss of contact with the extracellular matrix.
The granular epithelial layer contains apoptotic cells,
and the stratum corneum is characterized by keratin
cells of fibrils which form an extracellular barrier.14

METHODS
The sample of the research was determined using the
consecutive sampling method, where 30 HIV-positive
adult patients who met the research criteria at a given
time period were included in the research. Application
for permission to conduct the research is carried out
by submitting a proposal to the Ethics Committee
of the RSUP Dr. Hasan Sadikin Bandung to get the
legitimacy of the research. All patients included signed
a written agreement to participate in this research.
PCR microarrays are used to detect EBV in saliva,
while nested PCR is used to detect LMP1 in positive
EBV patients.
Salivary retrieval is done by the Navazeh method
(1993), which is the spitting method. In the spitting
method, the patient is instructed to collect saliva in
the mouth for 60 seconds then spit it into a tube that
has been prepared. This procedure is repeated for 5
minutes.18

After lytic replication in epithelial cells, the virus
spreads to all lymphoid tissues and infects naive B
cells through binding of glycoprotein gp350 virus
to the CD21 receptor on the B cell’s surface. The
infected B cells trigger specific primary cytotoxic cell
responses that ultimately control EBV infection. To
avoid T cells, EBV decreases the expression of antigens
that form a stable reservoir of the B cells’ memory,
where latent virus proteins are no longer expressed
and the EBV genome remains in the form of EBV
episomal.8 EBV encodes more than 85 genes. EBV will
induce proliferation of B cells through EBV nuclear
antigen (EBNA) expression, and two integral protein
membranes, namely latent membrane protein 1 (LMP1)
and LMP2A. Infected cells then enter the germinal
center of the lymph nodes, where EBV gene expression
is modified to avoid immunity. EBV subsequently
forms latent infections in the B cells’ memory.15

EBV detection is done by multiplexing PCR DNA
microarray.19,20 Primer for EBV gene sequences
fo r w a r d : C G CATA AT G G C G GAC C TAG
a n d r e v e r s e: CA A ACA AG C C CAC T C C C C .
P r o b e: 3′- A A AG ATAG CAG CAG C G CAG C ,
5′AACCATAGACCCGCTTCCTG. Detection of the
LMP1 EBV gene was carried out using nested PCR.21
Nested PCR reaction was carried out with a final
volume of 25 µL for each stage and the sample DNA
used in PCR stage 1 was diluted with a ratio of 1: 3
(DNA: dH2O free RNAse). For stage 1 PCR, 12.5
µL GoTaq Green Master Mix 2X (Promega) is added
with each 2.5 µL outer primary (Macrogen), FLMP11
(5’TGATTAGCTAAGGCATTCCCA3’), RLMPeco
(5 ‘CCGTACTGCCTCCGGCAGAC 3’), 6.5 ul dH2O
free RNAse (Promega) and 1 µL sample DNA. The
homogeneous mixture was then placed into Analytik
Jena’s Biometra thermal cycler with the first PCR
program which is 1 cycle of 95oC 2 minutes initials,
followed by 30 cycles of denaturation 95oC 1 minute,
primary attachment 63oC 30 seconds and installation
of 72oC nucleotide base (extension) 1 minute and 1 final
cycle extension 72oC 5 minutes. In stage 1 negative
control is included, where the DNA sample is replaced
with dH2O free RNAse.

Accurate genetic identification is very important for
epidemiological studies. Specific, sensitive, and new
molecular epidemiological techniques have been
developed to identify EBV genes, namely LMP1
gene-sequence variation patterns.16 LMP1 is the main
EBV oncoprotein, its expression is needed for EBV
latent infection and B cell’s transformation.14 EBV
infection in lymphocytes B generally occurs nonlytically and gives expression to membrane proteins
and nuclear proteins. EBV encodes LMP1 which is
a multifunctional oncoprotein that is important for
the proliferation and transformation of EBV-induced
B cells in vitro.6 Detection of the LMP1 gene is an
integral membrane protein that has been detected in
OHL. LMP1 modulates the growth and differentiation
of various cell types.14,17 This research aims at obtaining
data on EBV in saliva in HIV patients with PCR
microarray examination and detection of LMP1 gene
in EBV positive patients using nested PCR. This

Second phase PCR, as much as 12.5 µL GoTaq Green
Master Mix 2X (Promega) are added with each 2.5
µL primary inside (inner primer) (Macrogen): FA2 (5
‘GCCTATGACATGGTAATGCCTA 3’) and RE2 (5
‘ CTTTCCTCAACTGCCTTGCT 3 ‘), 5.5 µL dH2O
free RNAse (Promega) and 2 µL DNA results of PCR
82
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Table 1. Characteristics of the study participants
Total
n=30
n (%)
21 (70,0)
9 (30,0)

Variable
Gender
Male
Female
Age (Year)
Median (Min-Max)
Age Category
21-30 year
31-40 year
41-50 year
51-60 year
>60 year

30 (22 – 61)

Figure 3. Salivary EBV Distribution of the study participants
by means multiplexing PCR DNA microarray

n (%)
14 (46,7)
15 (50,0)
1 (3,3)

Table 2. Distribution of CD4 counts of study participants
Variable
CD4 (sel/mm3)
Median (Min-Maks)
Criteria CD4
≥ 500
350-499
200-349
< 200

Total
n=30
273 (17 – 790)
n (%)
6 (20,0)
5 (16,7)
7 (23,3)
12 (40)

Figure 4 . Distribution LMP1 gene of Research Subjects

stage 1. The mixture was homogeneous and then
placed into Analytik Jena thermal cycler Biometra with
PCR program stage 1 which is 1 cycle of initial 95oC
2 minutes, followed 35 cycles of denaturation 95oC
1 minute, primary attachment 68oC 30 seconds and
installation of nucleotide bases (extensions) 72oC 1.5
minutes and 1 final cycle extension 72oC 7 minutes. In
stage 2, the negative control DNA template was taken
from the negative control PCR phase 1.

Figure 5. Electrophoresis analysis of LMP1 gene with nested
PCR (1,500 bp) on 1.5% agarose gel. C -: negative control.
LMP1 + were on lane 1,2,3,4,7,8,9,10.

83.3%

Electrophoresis results of PCR were carried out using
agarose gel (Promega) concentrating 1.5% which was
given 2 ul dyes of Etidium Bromide (Sigma). The
agarose gel is placed into the electrophoresis tank
and given TAE 1X buffer until it is flooded. Each of
them has 5 ul negative control, 1 kbp DNA marker
(Promega), and the sample is inserted into the well in
the gel in sequence. Electrophoresis was carried out
with a voltage of 75V for 25 minutes. Electrophoretic
gel is placed on top of the UV laminator to visualize
DNA bands obtained and recorded with digital cameras.

16.7%

Figure 6. Prevalence of OHL in study participants with
HIV/AIDS

from January 2019 to February 2019. The samples
obtained were 30 subjects, consisting of 13 HIV/AIDS
patients who had not received ART and 17 HIV/AIDS
patients who had received ART.

RESULTS
This research was conducted in HIV patients who had
received ART and who had not received ART, with a
CD4 range of 17-790 cells/mm3. The research subjects
were patients who came to the Poliklinik Teratai at R.S.
Hasan Sadikin Bandung. The research was conducted

From the distribution of research subjects by sex, 21
(70%) men and 9 (30%) women were obtained. From
the distribution of research subjects based on age, the
highest results obtained in the age group of 31-40 years
83
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LMP1 also induces the expression of antiapoptotic
A20 molecules by activating NF-kB in epithelial cells
and lymphocytes. In normal epithelial cells, EGFR
expression is localized in the basal layer, whereas in
OHL high EGFR expression levels are detected in
suprabasal cells in the stratum spinosum. In normal
tissue, basal cells lose their proliferative ability when
migrating upwards into spinosum cells. Epidermal
growth factor receptor (EGFR) activates the pathway of
mitogen-activated protein kinase (MAPK) and provides
a stimulus for cell growth. Suprabasal EGFR detection
on OHL shows that spinosum cells retain the ability to
proliferate resulting in thickening of the spinosum cell
layer which is one of the characteristics of OHL.14,17

were 15 subjects (50%) and the lowest results is in the
age group of 40-49 years and there is ≥ 60 years as
many as 1 person (3.3%). Distribution of HIV/AIDS
patients based on sex and age can be seen in Table 1.
From the distribution of research subjects based on
CD4 counts, the highest results were 12 subjects (40%)
who had CD4 counts of <200 cells/mm3 and the lowest
were 5 subjects (16.7%) who had CD4 counts of 350499 cells/mm3. Distribution of CD4 counts can be seen
in Table 2.
Microarray PCR showed that of the 30 HIV/AIDS
patients, there were 26 subjects (87%) with positive
EBV and 4 subjects with negative EBV (13%). As
many as 13 subjects (38.24%) with EBV positive were
receiving ART and 15 subjects (47.05%) without ART.
This can be seen in Figure 3.

Some studies show that OHL is determined by the
expression of several genetic viruses that cause
infection and subsequent cell transformation, which
contribute to pathogenesis. The spinosa OHL cell
layer shows latent and lytic virus proteins that play
an important role in the development of lesions. 23
Previously, it has been shown that EBERs, a sign
of latent infection, are not expressed in OHL. The
characteristics of latent infection of EBNA2 and LMP1
have been detected in OHL in the stratum spinosum.24
The description of OHL microscopic characteristics is
epithelial hyperplasia, acanthosis, hyperkeratosis, and
balloon cells in the stratum spinosum, but with little
or no inflammatory cell infiltration in lamina propria
Hypha candida is generally absent, but if present
indicates a secondary fungal infection.25

The subjects of HIV / AIDS patients with positive
EBV who had LMP1 gene expression were 17 patients,
as shown in Figure 4. The results of electrophoresis
analysis of 1.5% LMP1 gene agarose gel with nested
PCR (1,500 bp) can be seen in Figure 5.
Of the 26 patients with positive EBV, only 5 subjects
(16.7%) had oral OHL lesions. OHL distribution of
study subjects can be seen in Figure 6.

DISCUSSION

OHL is a relatively common condition in HIV positive
patients associated with EBV infection. Accurate
diagnosis is important because it can be a marker
of immunodeficiency and early indicators of HIV
infection that are undiagnosed.22,23 Factors that play
a role in the emergence of OHL lesions by EBV
are immune system dysfunction and the absence of
Langerhans cells that have been observed in OHL.
EBV has been clinically observed in the epithelium of
HIV seropositive patients who can precede the onset
of OHL. OHL oral lesions in this research are the
same as in previous studies. It is in the form of white
plaque, asymptomatic, choppy, painless, not scraped,
and located on the lateral tongue, both unilateral or
bilateral, with a wavy or smooth surface.5 OHL is often
associated with HIV infection, commonly occurring in
50% of untreated HIV patients, especially on CD4 less
than 0.3 × 109 / L (normal 0.3–1.4 × 109 / L).26 There is
a positive correlation between OHL prevalence and a
decrease in the number of CD4 T cells (12%).27

Based on the characteristics of the research subjects,
this research consisted of 70.58% males and 29.42%
females, with the highest age range of 30-39 years
at 53.3%. The cumulative number of HIV infections
reported up to June 2018 was 301,959 people and most
were found in the age group of 20-24 years and 25-49
years. The highest immunosuppression rates from
CD4 counts in this research were found in the range
of <200 cells/mm3 as many as 12 patients. CD4 cell
count below 200 cells/mm3 is one of the predisposing
factors for the emergence of oral lesions in HIV/AIDS
patients. People with OHL generally have a moderate to
severe level of immunity suppression with an average
CD4 count of about 235 cells/mm3.22 The number of
patients with positive EBV in this research was 87%.
These results are close to the percentage in previous
studies that showed the serological prevalence of EBV
in adult humans worldwide, estimated at around 95%.5,6
According to Wolf, et al. (1984) EBV is present in
nasopharyngeal epithelial cells and salivary glands.
This shows the persistent location of the virus with
virus particles released at saliva.16

The previous research conducted by González, et al.
(2010) showed the same results, namely the expression
of a high LMP1 gene (84.6%) in patients with clinical
features of OHL, and research conducted by Walling, et
al. (2004) showed the LMP1 gene detected in 12 tongue
specimens with OHL (100%).23,28 According to Dawson,
et al. (2003), LMP1 is the main EBV protein involved

EBV expression of LMP1 and integral membrane
protein have been detected in OHL. LMP1 will alter
cell function by inducing cellular gene expression
and in epithelial cells by inducing EGFR expression.
84
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in molecular induction of cell surface adhesion and
antigen activation, regulation of anti-apoptotic proteins
(Bcl-2, A20), and stimulation of cytokine production
(interleukin-6 and interleukin-8). LMP1 is expressed
during EBIT lytic infection, and oral OHL lesions in
patients have high levels of LMP1 expression.14

3.
4.
5.

This research showed that 3 patients had CD4 of <200
cells/mm3 and 2 patients had CD4 of 200-349 cells/
mm3. This is consistent with the research conducted
by Bravo, et al. (2006). OHL is often associated with
HIV infection and a high CD4 cell count indicates a
decrease in the number of clinically opportunistic oral
lesions. Generally, OHL occurs in 50% of untreated
HIV patients, especially with CD4 less than 0.3×109/L
(normally 0.3–1.4×109/L).(26) Based on the average
(median), CD4 count of HIV-AIDS patients with
oral OHL lesions of 136 cells/mm 3 is lower than
patients who did not have oral OHL lesions, which is
260 cells/mm3. Research conducted by Kokila, et al.
(2014) showed that patients with OHL generally have
moderate to severe immunity suppression, with an
average CD4 count of 235 cells/mm3.29

6.

7.

8.

9.

CONCLUSION
10.

The high prevalence of EBV in saliva and LMP1 gene
are the risk factors for OHL. Early screening for EBV
infection in patients with HIV/AIDS is important to
prevent or reduce the risk of diseases caused by EBV
viruses such as OHL.
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